Changing phenotype of inflammatory bowel disease and neglected metabolic health

References

• Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., et al. (2017). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. The Lancet, 390, 2627–11. https://doi.org/https://doi.org/10.1016/S0140-6736(17)32129-3
   PubMed Web of Science ®Google Scholar
• Agar, R., Markham, C., Prendergast, M., Canning, R., Maher, E., Finn, C., . . . Maher, V. (2019). A snapshot of lipid levels in the republic of ireland in 2017. Irish Journal of Medical Science, 188(1), 241–247. https://doi.org/https://doi.org/10.1007/s11845-018-1820-3
   PubMed Web of Science ®Google Scholar
• Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., . . . Smith, S. C. (2009). Harmonizing the metabolic syndrome. A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation, 120(16), 1640–1645. https://doi.org/https://doi.org/10.1161/CIRCULATIONAHA.109.192644
   PubMed Web of Science ®Google Scholar
• Barrett, A., Burke, H., Cronin, H., Hickey, A., Kamiya, Y., Kenny, R. A., . . . Morgan, K. (May. 2011). Fifty plus in ireland 2011: First results from the irish longitudinal study on ageing (TILDA).Trinity College Dublin.
   Google Scholar
• Baumgart, D. C., & Sandborn, W. J. (2012). Crohn’s disease. The Lancet, 380(9853), 1590–1605. https://doi.org/https://doi.org/10.1016/S0140-6736(12)60026-9
   PubMed Web of Science ®Google Scholar
• Bryant, R. V., Trott, M. J., Bartholomeusz, F. D., & Andrews, J. M. (2013). Systematic review: Body composition in adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 38(3), 213–225. https://doi.org/https://doi.org/10.1111/apt.12372
   PubMed Web of Science ®Google Scholar
• Chan, S. S., Luben, R., Olsen, A., Tjonneland, A., Kaaks, R., Teucher, B., . . . Hart, A. R. (2013). Body mass index and the risk for crohn’s disease and ulcerative colitis: Data from a european prospective cohort study (The IBD in EPIC study). The American Journal of Gastroenterology, 108(4), 575–582. https://doi.org/https://doi.org/10.1038/ajg.2012.453
   PubMed Web of Science ®Google Scholar
• Chassaing, B., Ley, R. E., & Gewirtz, A. T. (2014). Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterol, 147(6), 1363–77.e17. https://doi.org/https://doi.org/10.1053/j.gastro.2014.08.033
   PubMed Web of Science ®Google Scholar
• De Nardo, D., & Latz, E. (2011). NLRP3 inflammasomes link inflammation and metabolic disease. Trends in Immunology, 32(8), 373–379. https://doi.org/https://doi.org/10.1016/j.it.2011.05.004
   PubMed Web of Science ®Google Scholar
• Dee, A., Callinan, A., Doherty, E., et al. (2015). Overweight and obesity on the island of Ireland: An estimation of costs. BMJ Open, 5(3), e006189. https://doi.org/https://doi.org/10.1136/bmjopen-2014-006189
   PubMed Web of Science ®Google Scholar
• Dhingra, R., & Vasan, R. S. (2012). Age as a cardiovascular risk factor. The Medical Clinics of North America, 96(1), 87–91. https://doi.org/https://doi.org/10.1016/j.mcna.2011.11.003
   PubMed Web of Science ®Google Scholar
• Dong, J., Chen, Y., Tang, Y., et al. (2015). Body mass index is associated with inflammatory bowel disease: A systematic review and meta-analysis. PLoS One, 10(12), e0144872. https://doi.org/https://doi.org/10.1371/journal.pone.0144872
   PubMed Web of Science ®Google Scholar
• Fitzmorris, P. S., Colantonio, L. D., Torrazza Perez, E., Smith, I., Kakati, D. D., & Malik, T. A. (2015). Impact of metabolic syndrome on the hospitalization rate of Crohn’s disease patients seen at a tertiary care center: A retrospective cohort study. Digestion, 91(3), 257–262. https://doi.org/https://doi.org/10.1159/000380763
   PubMed Web of Science ®Google Scholar
• Fitzmorris, P. S., Colantonio, L. D., Torrazza Perez, E., Smith, I., Kakati, D. D., & Malik, T. A. (2015). Obesity in inflammatory bowel disease: A marker of less severe disease. Digestive Diseases and Sciences, 60(8), 2436–2445. https://doi.org/https://doi.org/10.1007/s10620-015-3629-5
   PubMed Web of Science ®Google Scholar
• Goncalves, P., Magro, F., & Martel, F. (2015). Metabolic inflammation in inflammatory bowel disease: Crosstalk between adipose tissue and bowel. Inflammatory Bowel Diseases, 21(2), 453–467. https://doi.org/https://doi.org/10.1097/MIB.0000000000000209
   PubMed Web of Science ®Google Scholar
• Haas, L., Chevalier, R., Major, B. T., Enders, F., Kumar, S., & Tung, J. (2017). Biologic agents are associated with excessive weight gain in children with inflammatory bowel disease. Digestive Diseases and Sciences, 62(11), 3110–3116. https://doi.org/https://doi.org/10.1007/s10620-017-4745-1
   PubMed Web of Science ®Google Scholar
• Harper, J. W., Sinanan, M. N., & Zisman, T. L. (2013). Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 19(10), 2118–2124. https://doi.org/https://doi.org/10.1097/MIB.0b013e31829cf401
   PubMed Web of Science ®Google Scholar
• Levy, M., Thaiss, C. A., Zeevi, D., Dohnalova, L., Zilberman-Schapira, G., Mahdi, J. A., . . . Elinav, E. (2015). Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell, 163(6), 1428–1443. https://doi.org/https://doi.org/10.1016/j.cell.2015.10.048
   PubMed Web of Science ®Google Scholar
• Mendall, M., Harpsoe, M. C., Kumar, D., Andersson, M., & Jess, T. (2018). Relation of body mass index to risk of developing inflammatory bowel disease amongst women in the danish national birth cohort. PLoS One, 13(1), e0190600. https://doi.org/https://doi.org/10.1371/journal.pone.0190600
   PubMed Web of Science ®Google Scholar
• Michalak, A., Mosinska, P., & Fichna, J. (2016). Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives. Pharmacological Reports : PR, 68(4), 837–846. https://doi.org/https://doi.org/10.1016/j.pharep.2016.04.016
   PubMed Web of Science ®Google Scholar
• Mijac, D. D., Jankovic, G. L., Jorga, J., & Krstic, M. N. (2010). Nutritional status in patients with active inflammatory bowel disease: Prevalence of malnutrition and methods for routine nutritional assessment. European Journal of Internal Medicine, 21(4), 315–319. https://doi.org/https://doi.org/10.1016/j.ejim.2010.04.012
   PubMed Web of Science ®Google Scholar
• Mingrone, G., Benedetti, G., Capristo, E., De Gaetano, A., Greco, A. V., Tataranni, P. A., & Gasbarrini, G. (1998). Twenty-four-hour energy balance in Crohn disease patients: Metabolic implications of steroid treatment. The American Journal of Clinical Nutrition, 67(1), 118–123. https://doi.org/https://doi.org/10.1093/ajcn/67.1.118
   PubMed Web of Science ®Google Scholar
• Mohamed-Hussein, A. A., Mohamed, N. A., & Ibrahim, M. E. (2007). Changes in pulmonary function in patients with ulcerative colitis. Respiratory Medicine, 101(5), 977–982. https://doi.org/https://doi.org/10.1016/j.rmed.2006.09.005
   PubMed Web of Science ®Google Scholar
• Moran, C., Sheehan, D., & Shanahan, F. (2016). The changing phenotype of inflammatory bowel disease. Gastroenterology Research and Practice, 2016, 9. https://doi.org/https://doi.org/10.1155/2016/1619053
   Web of Science ®Google Scholar
• Nuttall, F. Q. (2015). Body mass index: obesity, BMI, and health: A critical review. Nutrition Today, 50(3), 117–128. https://doi.org/https://doi.org/10.1097/NT.0000000000000092
   PubMedGoogle Scholar
• Sato, F., Maeda, N., Yamada, T., et al. (2018). Association of epicardial, visceral, and subcutaneous fat with cardiometabolic diseases. Circulation Journal : Official Journal of the Japanese Circulation Society, 82(2), 502–508. https://doi.org/https://doi.org/10.1253/circj.CJ-17-0820
   PubMed Web of Science ®Google Scholar
• Seminerio, J. L., Koutroubakis, I. E., Ramos-Rivers, C., et al. (2015). Impact of obesity on the management and clinical course of patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 21(12), 2857–2863. https://doi.org/https://doi.org/10.1097/MIB.0000000000000560
   PubMed Web of Science ®Google Scholar
• Shanahan, F., & Sheehan, D. (2016). Microbial contributions to chronic inflammation and metabolic disease. Current Opinion in Clinical Nutrition and Metabolic Care, 19(4), 257–262. https://doi.org/https://doi.org/10.1097/MCO.0000000000000282
   PubMed Web of Science ®Google Scholar
• Shulzhenko, N., Morgun, A., Hsiao, W., et al. (2011). Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nature Medicine, 17(12), 1585–1593. https://doi.org/https://doi.org/10.1038/nm.2505
   PubMed Web of Science ®Google Scholar
• Singh, V., Yeoh, B. S., Carvalho, F., Gewirtz, A. T., & Vijay-Kumar, M. (2015). Proneness of TLR5 deficient mice to develop colitis is microbiota dependent. Gut Microbes, 6(4), 279–283. https://doi.org/https://doi.org/10.1080/19490976.2015.1060390
   PubMed Web of Science ®Google Scholar
• Steed, H., Walsh, S., & Reynolds, N. (2009). A brief report of the epidemiology of obesity in the inflammatory bowel disease population of tayside, scotland. Obesity Facts, 2(6), 370–372. https://doi.org/https://doi.org/10.1159/000262276
   PubMed Web of Science ®Google Scholar
• Swanson, S. M., Harper, J., & Zisman, T. L. (2018). Obesity and inflammatory bowel disease: Diagnostic and therapeutic implications. Current Opinion in Gastroenterology, 34(2), 112–119. https://doi.org/https://doi.org/10.1097/MOG.0000000000000422
   PubMed Web of Science ®Google Scholar
• Zietek, T., & Rath, E. (2016). Inflammation meets metabolic disease: gut feeling mediated by GLP-1. Frontiers in Immunology, 7, 154. https://doi.org/https://doi.org/10.3389/fimmu.2016.00154
   PubMed Web of Science ®Google Scholar